# The PK Study of the JLP-1207 and Solifenacin/Tamsulosin in Healthy Male Volunteers.

> **NCT02494349** · PHASE1 · COMPLETED · sponsor: **Jeil Pharmaceutical Co., Ltd.** · enrollment: 54 (actual)

## Conditions studied

- LUTS(Lower Urinary Tract Symptoms)
- Benign Prostatic Hyperplasia
- Overactive Bladder

## Interventions

- **DRUG:** JLP-1207
- **DRUG:** Solifenacin 5mg+Tamsulosin 0.2mg

## Key facts

- **NCT ID:** NCT02494349
- **Lead sponsor:** Jeil Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2015-11
- **Final completion:** 2015-12
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2016-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02494349

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02494349, "The PK Study of the JLP-1207 and Solifenacin/Tamsulosin in Healthy Male Volunteers.". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02494349. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*